These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35195401)

  • 1. Structure-Based Design of a Chemical Probe Set for the 5-HT
    Levit Kaplan A; Strachan RT; Braz JM; Craik V; Slocum S; Mangano T; Amabo V; O'Donnell H; Lak P; Basbaum AI; Roth BL; Shoichet BK
    J Med Chem; 2022 Mar; 65(5):4201-4217. PubMed ID: 35195401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactive and active state structures template selective tools for the human 5-HT
    Zhang S; Chen H; Zhang C; Yang Y; Popov P; Liu J; Krumm BE; Cao C; Kim K; Xiong Y; Katritch V; Shoichet BK; Jin J; Fay JF; Roth BL
    Nat Struct Mol Biol; 2022 Jul; 29(7):677-687. PubMed ID: 35835867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering the unique characteristics of different groups of 5-HT
    Kordylewski SK; Bugno R; Bojarski AJ; Podlewska S
    Pharmacol Rep; 2024 Jul; ():. PubMed ID: 38971919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of spinal 5-HT5A, and 5-HT1A/1B/1D, receptors in neuropathic pain induced by spinal nerve ligation in rats.
    Avila-Rojas SH; Velázquez-Lagunas I; Salinas-Abarca AB; Barragán-Iglesias P; Pineda-Farias JB; Granados-Soto V
    Brain Res; 2015 Oct; 1622():377-85. PubMed ID: 26168890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal 5-HT₅A receptors mediate 5-HT-induced antinociception in several pain models in rats.
    Muñoz-Islas E; Vidal-Cantú GC; Bravo-Hernández M; Cervantes-Durán C; Quiñonez-Bastidas GN; Pineda-Farias JB; Barragán-Iglesias P; Granados-Soto V
    Pharmacol Biochem Behav; 2014 May; 120():25-32. PubMed ID: 24517902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 5-HT5A and 5-HT1B/1D receptors in the antinociception produced by ergotamine and valerenic acid in the rat formalin test.
    Vidal-Cantú GC; Jiménez-Hernández M; Rocha-González HI; Villalón CM; Granados-Soto V; Muñoz-Islas E
    Eur J Pharmacol; 2016 Jun; 781():109-16. PubMed ID: 27068146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-induced phase advances of SCN neuronal firing in vitro: a possible role for 5-HT5A receptors?
    Sprouse J; Reynolds L; Braselton J; Schmidt A
    Synapse; 2004 Nov; 54(2):111-8. PubMed ID: 15352136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GR-127935-sensitive mechanism mediating hypotension in anesthetized rats: are 5-HT5B receptors involved?
    Sánchez-Maldonado C; López-Sánchez P; Anguiano-Robledo L; Leopoldo M; Lacivita E; Terrón JA
    J Cardiovasc Pharmacol; 2015 Apr; 65(4):335-41. PubMed ID: 25502305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.
    Nikiforuk A; Hołuj M; Kos T; Popik P
    Neuropharmacology; 2016 Jun; 105():351-360. PubMed ID: 26826431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites.
    Kuipers W; Van Wijngaarden I; Ijzerman AP
    Drug Des Discov; 1994 Apr; 11(3):231-49. PubMed ID: 7548638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional mechanism of ASP5736, a selective serotonin 5-HT
    Yamazaki M; Yamamoto N; Yarimizu J; Okabe M; Moriyama A; Furutani M; Marcus MM; Svensson TH; Harada K
    Eur Neuropsychopharmacol; 2018 May; 28(5):620-629. PubMed ID: 29571967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-ht5A receptors as a therapeutic target.
    Thomas DR
    Pharmacol Ther; 2006 Sep; 111(3):707-14. PubMed ID: 16516972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memories are made of this (perhaps): a review of serotonin 5-HT(6) receptor ligands and their biological functions.
    Russell MG; Dias R
    Curr Top Med Chem; 2002 Jun; 2(6):643-54. PubMed ID: 12052198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis.
    Wang YQ; Lin WW; Wu N; Wang SY; Chen MZ; Lin ZH; Xie XQ; Feng ZW
    Acta Pharmacol Sin; 2019 Sep; 40(9):1138-1156. PubMed ID: 30814658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats.
    Yamazaki M; Okabe M; Yamamoto N; Yarimizu J; Harada K
    J Pharmacol Sci; 2015 Mar; 127(3):362-9. PubMed ID: 25837935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors.
    Mahé C; Loetscher E; Feuerbach D; Müller W; Seiler MP; Schoeffter P
    Eur J Pharmacol; 2004 Jul; 495(2-3):97-102. PubMed ID: 15249157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists of the serotonin receptor 5A target human breast tumor initiating cells.
    Gwynne WD; Shakeel MS; Girgis-Gabardo A; Kim KH; Ford E; Dvorkin-Gheva A; Aarts C; Isaac M; Al-Awar R; Hassell JA
    BMC Cancer; 2020 Aug; 20(1):724. PubMed ID: 32758183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore models for metabotropic 5-HT receptor ligands.
    Bojarski AJ
    Curr Top Med Chem; 2006; 6(18):2005-26. PubMed ID: 17017971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors.
    Thomas DR; Atkinson PJ; Ho M; Bromidge SM; Lovell PJ; Villani AJ; Hagan JJ; Middlemiss DN; Price GW
    Br J Pharmacol; 2000 May; 130(2):409-17. PubMed ID: 10807680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
    Schlicker E; Fink K; Molderings GJ; Price GW; Duckworth M; Gaster L; Middlemiss DN; Zentner J; Likungu J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):321-7. PubMed ID: 9303568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.